Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zangdi Babao Tablets for Male Infertility
ChiCTR2500108085Phase 4Not yet recruiting
- Sponsor
- Reproductive Hospital affiliated with Shandong University
- Start
- Aug 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Zangdi Babao Tablets in male infertility (2 arms), sponsored by Reproductive Hospital affiliated with Shandong University. Primary endpoint: sperm progressive motility rate. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
Zangdi Babao Tablets
03
Conditions
male infertility
Beyond the preview
Go deeper on ChiCTR2500108085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108085.